FARHAD AMIRI: Open Payments
NPI 1154703361 · SOUTHFIELD, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$29,522 in 144 payments from 20 companies in 2025. Trend: 2023 $3,071 · 2024 $2,465 · 2025 $29,522
Honoraria: $25,025Food & beverage: $3,857Travel & lodging: $588Education: $52
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 40 | $27,135 |
| ABBVIE INC. | 15 | $384 |
| E.R. Squibb & Sons, L.L.C. | 9 | $345 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 15 | $276 |
| Alkermes, Inc. | 14 | $207 |
| Vanda Pharmaceuticals Inc. | 7 | $167 |
| Neuronetics, Inc. | 3 | $148 |
| Noven Therapeutics, LLC | 7 | $143 |
| Otsuka America Pharmaceutical, Inc. | 9 | $136 |
| Lundbeck LLC | 6 | $126 |
Products named: Auvelity, VRAYLAR, CAPLYTA, COBENFY, REXULTI, ARISTADA, FANAPT, NEUROSTAR TMS THERAPY SYSTEM.
Industry payments across MI — which companies pay providers there.
